| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Seong Cheol Jeong, Jae Jun Kim, Si Young Choi, Yong Hwan Kim, In Sub Ki. Successful surgical treatment of massive spontaneous hemothorax due to intrathoracic secondary degeneration of a neurofibroma from mediastinal involvement of type 1 neurofibromatosis. Journal of thoracic disease. vol 10. issue 3. 2020-09-30. PMID:29707374. |
final pathology revealed that the tumor was cystic hemorrhagic degeneration of a neurofibroma from mediastinal involvement of nf1. |
2020-09-30 |
2023-08-13 |
Not clear |
| Reinhard E Friedrich, Christian Hage. Pigmented (melanotic) diffuse neurofibroma of the back in neurofibromatosis type 1. GMS Interdisciplinary plastic and reconstructive surgery DGPW. vol 7. 2020-09-30. PMID:30112270. |
multiple neurofibromas are among the characteristic tumors of nf1. |
2020-09-30 |
2023-08-13 |
Not clear |
| Reinhard E Friedrich, Christian Hage. Pigmented (melanotic) diffuse neurofibroma of the back in neurofibromatosis type 1. GMS Interdisciplinary plastic and reconstructive surgery DGPW. vol 7. 2020-09-30. PMID:30112270. |
the report describes the diagnosis and treatment of a large spinal neurofibroma in a nf1 patient. |
2020-09-30 |
2023-08-13 |
Not clear |
| Toshiaki Komo, Koichi Oishi, Toshihiko Kohashi, Jun Hihara, Masanori Yoshimitsu, Noriaki Tokumoto, Mikihiro Kanou, Akira Nakashima, Yoshirou Aoki, Manabu Shimomura, Masashi Miguchi, Mahito Funakoshi, Hidenori Mukaida, Mayumi Kaneko, Hiroo Matuura, Naoki Hirabayash. Appendiceal neurofibroma with low-grade appendiceal mucinous neoplasm in neurofibromatosis type 1 patient: A case report. International journal of surgery case reports. vol 53. 2020-09-30. PMID:30481737. |
neurofibromas are a characteristic of the autosomal dominant disorder neurofibromatosis type 1 (nf1), also known as von recklinghausen's disease. |
2020-09-30 |
2023-08-13 |
Not clear |
| Toshiaki Komo, Koichi Oishi, Toshihiko Kohashi, Jun Hihara, Masanori Yoshimitsu, Noriaki Tokumoto, Mikihiro Kanou, Akira Nakashima, Yoshirou Aoki, Manabu Shimomura, Masashi Miguchi, Mahito Funakoshi, Hidenori Mukaida, Mayumi Kaneko, Hiroo Matuura, Naoki Hirabayash. Appendiceal neurofibroma with low-grade appendiceal mucinous neoplasm in neurofibromatosis type 1 patient: A case report. International journal of surgery case reports. vol 53. 2020-09-30. PMID:30481737. |
appendiceal neurofibromas are extremely rare, and low-grade appendiceal mucinous neoplasms (lamns) have not previously been reported in nf1. |
2020-09-30 |
2023-08-13 |
Not clear |
| Kristjan R Jessen, Rhona Mirsk. Schwann Cell Precursors; Multipotent Glial Cells in Embryonic Nerves. Frontiers in molecular neuroscience. vol 12. 2020-09-30. PMID:30971890. |
scp, as well as closely related cells termed boundary cap cells, and later stages of the schwann cell lineage have all been implicated as the tumor initiating cell in nf1 associated neurofibromas. |
2020-09-30 |
2023-08-13 |
Not clear |
| Julia Pinheiro Martinez Serrano, Maick Willen Fernandes Neves, Cassiano Marchi, Fabio Jundy Nakasone, Marcos Vinicius Calfat Maldaun, Paulo Henrique Pires de Aguiar, Wilson Scappin. Giant dumbbell C2C3 neurofibroma invading prebulbar cistern: Case report and literature review. Surgical neurology international. vol 10. 2020-09-30. PMID:31528415. |
neurofibromatosis 1 (nf1) has a broad spectrum of clinical manifestations, most typically involving café-au-lait spots and skin neurofibromas. |
2020-09-30 |
2023-08-13 |
Not clear |
| Chang Yeon Jung, Jung Min Bae, Joon Hyuk Choi, Ki Hoon Jun. Superficial malignant peripheral nerve sheath tumor from recurrent neurofibroma in the abdominal wall of a patient without neurofibromatosis type 1. Yeungnam University journal of medicine. vol 36. issue 1. 2020-09-30. PMID:31620615. |
herein, we report an unusual case of superficial mpnst from a recurrent neurofibroma in a patient without nf1. |
2020-09-30 |
2023-08-13 |
Not clear |
| Omar Hegazy, Howard Platnic. Cannabidiol (CBD) for Treatment of Neurofibromatosis-related Pain and Concomitant Mood Disorder: A Case Report. Cureus. vol 11. issue 12. 2020-09-30. PMID:31938604. |
visible neurofibromas add significant psychosocial distress for nf1 patients. |
2020-09-30 |
2023-08-13 |
Not clear |
| Nolan Mann, Truong Ma, Arthur Dalto. Neurofibromatosis type 1 and male breast cancer: emerging risk factor? Journal of surgical case reports. vol 2017. issue 7. 2020-09-29. PMID:28852451. |
neurofibromatosis type 1 (nf1) is an autosomal dominant disorder characterized by the appearance of cafe au lait spots, neurofibromas and lisch nodules. |
2020-09-29 |
2023-08-13 |
Not clear |
| Leitao Huang, Yi Ding, Lai Qi, Xia Wu, Wei Li, Gendong Huang, Min Dai, Bing Zhan. Repeated Multiple Neurofibromatosis Type 1 in the Right Lower Limb: A Case Report. World journal of oncology. vol 8. issue 2. 2020-09-29. PMID:29147436. |
neurofibromatosis type 1 (nf1) is an autosomal-dominant genetic disease characterized by the presence of multiple neurofibromas. |
2020-09-29 |
2023-08-13 |
Not clear |
| Leitao Huang, Yi Ding, Lai Qi, Xia Wu, Wei Li, Gendong Huang, Min Dai, Bing Zhan. Repeated Multiple Neurofibromatosis Type 1 in the Right Lower Limb: A Case Report. World journal of oncology. vol 8. issue 2. 2020-09-29. PMID:29147436. |
we encountered a unique case of nf1 that manifested as a recurrent soft tissue neurofibroma in the right lower limb that developed over a period of 16 years. |
2020-09-29 |
2023-08-13 |
Not clear |
| Matilde Taddei, Alessandra Erbetta, Silvia Esposito, Veronica Saletti, Sara Bulgheroni, Daria Riv. Brain Tumors in NF1 Children: Influence on Neurocognitive and Behavioral Outcome. Cancers. vol 11. issue 11. 2020-09-28. PMID:31717965. |
nf1 patients are at risk to develop neurofibromas and other tumors, such as optic pathway gliomas and other tumors of the central nervous system. |
2020-09-28 |
2023-08-13 |
Not clear |
| Yang Wang, Xiao-Fan Lu, Lu-Lu Chen, Ying-Wei Zhang, Bing Zhan. Multiple neurofibromas plus fibrosarcoma with familial NF1 pathogenicity: A case report. World journal of clinical cases. vol 8. issue 7. 2020-09-28. PMID:32337207. |
multiple neurofibromas plus fibrosarcoma with familial nf1 pathogenicity: a case report. |
2020-09-28 |
2023-08-13 |
Not clear |
| Fabienne Wotjiuk, Isabelle Hyon, Sylvie Dajean-Trutaud, Zahi Badran, Tony Prud'homm. Dental Management of Neurofibromatosis Type 1: A Case Report and Literature Review. International journal of clinical pediatric dentistry. vol 12. issue 6. 2020-09-28. PMID:32440079. |
neurofibromatosis type 1 (nf1) is a clinically heterogeneous neurocutaneous genetic disorder that manifests in the form of coffee-milk spots on the skin, lish nodules, lentigines on the underarms and on the inguinal region, and neurofibromas. |
2020-09-28 |
2023-08-13 |
Not clear |
| Nicolas Ortonne, Steven L Carroll, Fausto J Rodriguez, Douglas C Miller, Rosalynn M Nazarian, Jaishri O Blakeley, Zachary B Madaj, Sharad K Verma, Anat Stemmer-Rachamimo. Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass. Neuro-oncology advances. vol 2. issue Suppl 1. 2020-09-28. PMID:32642737. |
cutaneous neurofibromas (cnfs) are the most common tumors in people with neurofibromatosis type 1 (nf1) and are associated with reduced quality of life. |
2020-09-28 |
2023-08-13 |
Not clear |
| Bahir H Chamseddin, Lu Q L. Management of cutaneous neurofibroma: current therapy and future directions. Neuro-oncology advances. vol 2. issue Suppl 1. 2020-09-28. PMID:32642736. |
neurofibromatosis type 1 (nf1) is a life-long neurocutaneous disorder characterized by a predisposition to tumor development, including cutaneous neurofibroma (cnf), the hallmark of the disease. |
2020-09-28 |
2023-08-13 |
Not clear |
| Sadhana Jackson, Eva H Baker, Andrea M Gross, Patricia Whitcomb, Andrea Baldwin, Joanne Derdak, Cecilia Tibery, Jennifer Desanto, Amanda Carbonell, Kaleb Yohay, Geraldine O'Sullivan, Alice P Chen, Brigitte C Widemann, Eva Domb. The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas. Neuro-oncology advances. vol 2. issue 1. 2020-09-28. PMID:32939452. |
the mek inhibitor selumetinib reduces spinal neurofibroma burden in patients with nf1 and plexiform neurofibromas. |
2020-09-28 |
2023-08-13 |
Not clear |
| Sadhana Jackson, Eva H Baker, Andrea M Gross, Patricia Whitcomb, Andrea Baldwin, Joanne Derdak, Cecilia Tibery, Jennifer Desanto, Amanda Carbonell, Kaleb Yohay, Geraldine O'Sullivan, Alice P Chen, Brigitte C Widemann, Eva Domb. The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas. Neuro-oncology advances. vol 2. issue 1. 2020-09-28. PMID:32939452. |
spinal neurofibromas (snfs) in neurofibromatosis type 1 (nf1) can cause progressive spinal cord compression and neurological dysfunction. |
2020-09-28 |
2023-08-13 |
Not clear |
| Bahir H Chamseddin, La'Nette Hernandez, Dezehree Solorzano, Juan Vega, Lu Q L. Robust surgical approach for cutaneous neurofibroma in neurofibromatosis type 1. JCI insight. vol 5. 2020-09-21. PMID:31038470. |
cutaneous neurofibromas (cnf) are physically disfiguring, painful, and cause extensive psychologic harm in patients with neurofibromatosis type 1 (nf1). |
2020-09-21 |
2023-08-13 |
Not clear |